# ZEAMAP v0.1 Stage 5.19 ARS Reproducibility Review

日期：2026-06-06

Workflow basis: academic-research-suite methodology/reproducibility reviewer gate.

## Decision

`minor_revision_after_crosswalk`

## Assessment

The project now has a concrete claim-to-script crosswalk for the main dataset construction, prediction benchmark, methylation decision, GEMMA LMM GWAS, candidate annotation, figure generation, manuscript assembly and submission gates. This directly addresses Stage 5.18 risks R02 and R05.

The remaining reproducibility risk is not conceptual; it is packaging. Some large local data paths are present on this workstation but are not Git-tracked, so they must be described as public-source inputs or regenerated artifacts in the final Data/Code Availability statement.

## Missing Path Audit

_No missing crosswalk paths._

## Recommendation

Use the Stage 5.19 crosswalk as the canonical reproducibility appendix. The next machine-executable step should be a compact GWAS diagnostic appendix table, because Stage 5.18 identified that as the next strongest statistical reviewer risk.
